Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionClarius Group, LLC
Latest Disclosed Ownership6,583 shares
Latest Disclosed Value $ 807,997
Clarius Group, LLC reports 0.23% decrease in ownership of GILD / Gilead Sciences, Inc.

On January 14, 2026 - Clarius Group, LLC filed a 13F-HR form disclosing ownership of 6,583 shares of Gilead Sciences, Inc. (US:GILD) valued at $807,997 USD as of December 31, 2025. The entity filed a previous 13F-HR on October 14, 2025 disclosing 6,598 shares of Gilead Sciences, Inc.. This represents a change in shares of -0.23% during the quarter. The current value of the position is $849,141 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-14 2025-12-31 13F GILEAD SCIENCES COM 375558103 6,583 -15 -0.23 808 10.25 0.0461
2025-10-14 2025-09-30 13F GILEAD SCIENCES COM 375558103 6,598 -2,155 -24.62 732 -24.54 0.0434
2025-07-22 2025-06-30 13F GILEAD SCIENCES COM 375558103 8,753 445 5.36 970 4.30 0.0566
2025-04-18 2025-03-31 13F GILEAD SCIENCES COM 375558103 8,308 1,460 21.32 931 47.15 0.0585
2025-01-16 2024-12-31 13F GILEAD SCIENCES COM 375558103 6,848 -175 -2.49 633 7.85 0.0432
2024-10-09 2024-09-30 13F GILEAD SCIENCES COM 375558103 7,023 -278 -3.81 587 17.20 0.0412
2024-07-11 2024-06-30 13F GILEAD SCIENCES COM 375558103 7,301 -221 -2.94 501 -9.09 0.0355
2024-04-17 2024-03-31 13F GILEAD SCIENCES COM 375558103 7,522 -2,319 -23.56 551 -30.99 0.0380
2024-01-29 2023-12-31 13F GILEAD SCIENCES COM 375558103 9,841 360 3.80 797 12.25 0.0661
2023-10-19 2023-09-30 13F GILEAD SCIENCES COM 375558103 9,481 -3,559 -27.29 710 -29.35 0.0677
2023-08-10 2023-06-30 13F GILEAD SCIENCES COM 375558103 13,040 34 0.26 1,005 -6.86 0.0777
2023-04-17 2023-03-31 13F GILEAD SCIENCES COM 375558103 13,006 1,098 9.22 1,079 107,800.00 0.0916
2023-01-25 2022-12-31 13F GILEAD SCIENCES COM 375558103 11,908 923 8.40 1 -99.85 0.0920
2022-10-24 2022-09-30 13F GILEAD SCIENCES COM 375558103 10,985 4,664 73.79 678 73.40 0.0678
2022-08-10 2022-06-30 13F GILEAD SCIENCES COM 375558103 6,321 -4,074 -39.19 391 -48.21 0.0390
2022-04-08 2022-03-31 13F GILEAD SCIENCES COM 375558103 10,395 0 0.00 755 0.00 0.0597
2022-02-02 2021-12-31 13F GILEAD SCIENCES COM 375558103 10,395 747 7.74 755 12.02 0.0597
2021-10-18 2021-09-30 13F GILEAD SCIENCES COM 375558103 9,648 344 3.70 674 5.15 0.0604
2021-08-06 2021-06-30 13F GILEAD SCIENCES COM 375558103 9,304 20 0.22 641 6.83 0.0575
2021-04-27 2021-03-31 13F GILEAD SCIENCES COM 375558103 9,284 3,573 62.56 600 80.18 0.0588
2021-01-15 2020-12-31 13F GILEAD SCIENCES COM 375558103 5,711 -918 -13.85 333 -20.53 0.0359
2020-10-09 2020-09-30 13F GILEAD SCIENCES COM 375558103 6,629 -4,162 -38.57 419 -49.52 0.0538
2020-07-08 2020-06-30 13F GILEAD SCIENCES COM 375558103 10,791 1,538 16.62 830 19.94 0.1163
2020-04-24 2020-03-31 13F GILEAD SCIENCES COM 375558103 9,253 1,171 14.49 692 33.59 0.1305
2020-01-22 2019-12-31 13F GILEAD SCIENCES COM 375558103 8,082 572 7.62 518 8.82 0.0820
2019-10-22 2019-09-30 13F GILEAD SCIENCES COM 375558103 7,510 1,140 17.90 476 10.70 0.0873
2019-08-02 2019-06-30 13F GILEAD SCIENCES COM 375558103 6,370 1,234 24.03 430 28.74 0.0865
2019-05-14 2019-03-31 13F GILEAD SCIENCES COM 375558103 5,136 1,703 49.61 334 55.35 0.0812
2019-02-09 2018-12-31 13F GILEAD SCIENCES COM 375558103 3,433 3,433 215 0.0781
2016-08-12 2016-06-30 13F GILEAD SCIENCES COM 375558103 0 -2,505 -100.00 0 -100.00
2016-05-10 2016-03-31 13F GILEAD SCIENCES COM 375558103 2,505 -141 -5.33 230 -13.86 0.1275
2016-05-10 2015-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 2,646 2,646 267 0.1548
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.